161 related articles for article (PubMed ID: 33932486)
21. Prokineticins and their G protein-coupled receptors in health and disease.
Zhao Y; Wu J; Wang X; Jia H; Chen DN; Li JD
Prog Mol Biol Transl Sci; 2019; 161():149-179. PubMed ID: 30711026
[TBL] [Abstract][Full Text] [Related]
22. Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population.
Kishi T; Kitajima T; Tsunoka T; Okumura T; Ikeda M; Okochi T; Kinoshita Y; Kawashima K; Yamanouchi Y; Ozaki N; Iwata N
Neuromolecular Med; 2009; 11(2):114-22. PubMed ID: 19544013
[TBL] [Abstract][Full Text] [Related]
23. Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity.
Severini C; Lattanzi R; Maftei D; Marconi V; Ciotti MT; Petrocchi Passeri P; Florenzano F; Del Duca E; Caioli S; Zona C; Balboni G; Salvadori S; Nisticò R; Negri L
Sci Rep; 2015 Oct; 5():15301. PubMed ID: 26477583
[TBL] [Abstract][Full Text] [Related]
24. Prokineticin Ligands and Receptors Are Expressed in the Human Fetal Ovary and Regulate Germ Cell Expression of COX2.
Eddie SL; Childs AJ; Kinnell HL; Brown P; Jabbour HN; Anderson RA
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1197-205. PubMed ID: 26192875
[TBL] [Abstract][Full Text] [Related]
25. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency.
Moya-Plana A; Villanueva C; Laccourreye O; Bonfils P; de Roux N
Eur J Endocrinol; 2013 Jan; 168(1):31-7. PubMed ID: 23082007
[TBL] [Abstract][Full Text] [Related]
26. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
[TBL] [Abstract][Full Text] [Related]
27. Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations.
Sbai O; Monnier C; Dodé C; Pin JP; Hardelin JP; Rondard P
FASEB J; 2014 Aug; 28(8):3734-44. PubMed ID: 24830383
[TBL] [Abstract][Full Text] [Related]
28. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
Brioude F; Bouvattier CE; Lombès M
Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
[TBL] [Abstract][Full Text] [Related]
29. Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer.
Kurebayashi H; Goi T; Shimada M; Tagai N; Naruse T; Nakazawa T; Kimura Y; Hirono Y; Yamaguchi A
Oncotarget; 2015 Sep; 6(28):26242-51. PubMed ID: 26317645
[TBL] [Abstract][Full Text] [Related]
30. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
Kim SH; Hu Y; Cadman S; Bouloux P
J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
[TBL] [Abstract][Full Text] [Related]
31. Kallmann syndrome in women: from genes to diagnosis and treatment.
Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
[TBL] [Abstract][Full Text] [Related]
32. [Kallmann syndrome: a historical [corrected] clinical and molecular review].
Ribeiro RS; Abucham J
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):8-17. PubMed ID: 18345392
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of Diabetes.
Castelli M; Amodeo G; Negri L; Lattanzi R; Maftei D; Gotti C; Pistillo F; Onnis V; Congu C; Panerai AE; Sacerdote P; Franchi S
PLoS One; 2016; 11(1):e0146259. PubMed ID: 26730729
[TBL] [Abstract][Full Text] [Related]
34. Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human Pathology.
Lattanzi R; Maftei D; Petrella C; Pieri M; Sancesario G; Schirinzi T; Bernardini S; Barbato C; Ralli M; Greco A; Possenti R; Sancesario G; Severini C
Cells; 2019 Nov; 8(11):. PubMed ID: 31766244
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic and genotypic landscape of PROKR2 in neuroendocrine disorders.
Martinez-Mayer J; Perez-Millan MI
Front Endocrinol (Lausanne); 2023; 14():1132787. PubMed ID: 36843573
[TBL] [Abstract][Full Text] [Related]
36. PROK2/PROKR2 Signaling and Kallmann Syndrome.
Dodé C; Rondard P
Front Endocrinol (Lausanne); 2013; 4():19. PubMed ID: 23596439
[TBL] [Abstract][Full Text] [Related]
37. Activation of amygdala prokineticin receptor 2 neurons drives the anorexigenic activity of the neuropeptide PK2.
Yin TC; Mittal A; Buscaglia P; Li W; Sebag JA
J Biol Chem; 2023 Jan; 299(1):102814. PubMed ID: 36539034
[TBL] [Abstract][Full Text] [Related]
38. Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.
Sinisi AA; Asci R; Bellastella G; Maione L; Esposito D; Elefante A; De Bellis A; Bellastella A; Iolascon A
Hum Reprod; 2008 Oct; 23(10):2380-4. PubMed ID: 18596028
[TBL] [Abstract][Full Text] [Related]
39. Triallelic digenic mutation in the prokineticin 2 and GNRH receptor genes in two brothers with normosmic congenital hypogonadotropic hypogonadism.
Méndez JP; Zenteno JC; Coronel A; Soriano-Ursúa MA; Valencia-Villalvazo EY; Soderlund D; Coral-Vázquez RM; Canto P
Endocr Res; 2015; 40(3):166-71. PubMed ID: 25531638
[TBL] [Abstract][Full Text] [Related]
40. The puzzles of the prokineticin 2 pathway in human reproduction.
Balasubramanian R; Plummer L; Sidis Y; Pitteloud N; Martin C; Zhou QY; Crowley WF
Mol Cell Endocrinol; 2011 Oct; 346(1-2):44-50. PubMed ID: 21664414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
